Amicus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

PHILADELPHIA, Jan. 03, 2023 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that Bradley Campbell, President and Chief Executive Officer, will present at the 41

st

Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 9, 2023 at 2:15 p.m. PT.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at

https://ir.amicusrx.com/events-and-presentations

.



About Amicus Therapeutics



Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at


www.amicusrx.com


, and follow on


Twitter


and


LinkedIn


.

CONTACT:


Investors:


Amicus Therapeutics

Andrew Faughnan

Executive Director, Investor Relations


[email protected]


(609) 662-3809


Media:


Amicus Therapeutics

Diana Moore

Head of Global Communications


[email protected]


(609) 662-5079

FOLD–G



Primary Logo